Mechanisms of receptor tyrosine kinase activation in cancer
Zhenfang Du(Chinese University of Hong Kong), Christine M. Lovly(Vanderbilt University)
Cited by 1,053
Related Papers
Routine Multiplex Mutational Profiling of Melanomas Enables Enrollment in Genotype-Driven Therapeutic Trials
|PLoS ONE|2012|203
Expression of ROS1 predicts ROS1 gene rearrangement in inflammatory myofibroblastic tumors
|Modern Pathology|2015|107
Structure–function analysis of oncogenic EGFR Kinase Domain Duplication reveals insights into activation and a potential approach for therapeutic targeting
|Nature Communications|2021|70
The epigenetic modifier CHD5 functions as a novel tumor suppressor for renal cell carcinoma and is predominantly inactivated by promoter CpG methylation
|Oncotarget|2016|28
Allele-specific activation, enzyme kinetics, and inhibitor sensitivities of EGFR exon 19 deletion mutations in lung cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2022|3